Fetal heart monitoring is a common practice used by healthcare providers to examine a baby’s heart rate during the latter ...

Please provide your email address to receive an email when new articles are posted on . An AI software system improved ultrasound detection of fetal congenital heart defects compared with unaided ...

Medical devicemaker BrightHeart has earned FDA clearance for its artificial intelligence software designed to transform prenatal ultrasound evaluations of the fetal heart. Congenital heart defects ...

The second study, “Artificial Intelligence System Accurately Detects Fetal Ultrasound Findings Suspicious For Major Congenital Heart Defects,” analyzed a total of 877 ultrasound exams from 11 centers ...

PARIS--(BUSINESS WIRE)--BrightHeart, a leading AI innovator in obstetric and pediatric cardiology technology, announces it has received FDA 510(k) clearance for its first artificial intelligence ...

PARIS--(BUSINESS WIRE)--BrightHeart, a leading AI innovator in obstetric and pediatric cardiology technology, announced today that the groundbreaking results of two key studies of the company’s ...

BrightHeart, a pioneer in AI-driven prenatal ultrasound evaluation, today announced the publication of its landmark study in Obstetrics & Gynecology, commonly known as the Green Journal. The study, ...